Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody.
DeNardo GL, DeNardo SJ, Lamborn KR, Goldstein DS, Levy NB, Lewis JP, O'Grady LF, Raventos A, Kroger LA, Macey DJ, McGahan JP, Mills SL, Shen S.
DeNardo GL, et al. Among authors: levy nb.
Cancer Biother Radiopharm. 1998 Aug;13(4):239-54. doi: 10.1089/cbr.1998.13.239.
Cancer Biother Radiopharm. 1998.
PMID: 10850360
Clinical Trial.